On April 24, 2025, Mangoceuticals acquired intellectual property from Smokeless Technology Corp. related to oral pouch delivery products, paying with 1.6 million restricted shares and agreeing to 10% royalties on future sales.

Mangoceuticals also signed a consulting agreement with Strategem Solutions for support in developing the pouch division, involving monthly payments and stock grants. Additionally, CEO Jacob D. Cohen's employment agreement was amended to increase salary, allowances, and award him more shares in subsidiary Mango & Peaches Corp., giving him 49% ownership and future voting control.